Table 3 Elucidation of demographic assessments as observed in the included articles
Author ID | Year | Cellular type assessed | Sample type | Study protocol | Assessment period (in weeks) | Metastatic parameter assessed |
|---|---|---|---|---|---|---|
Berta et al. [9] | 2010 | HCPC I | SGHs | In-vivo | 14 | Neoplastic proliferation |
Masuelli et al. [10] | 2014 | CAL-27 and SCC-15 | Balb/c mice | In-vivo | 30 | Neoplastic apoptosis |
Pradhan et al. [11] | 2021 | H-357 and THP-1 | Balb/c mice | In-vivo | 3.5 | Neoplastic proliferation |
Shrotriya et al. [12] | 2015 | Unspecified | C57BL/6 mice | In-vivo | 16 | Neoplastic proliferation |
Uzawa et al. [13] | 2019 | SAS, Sa3, and HSC-3 | Balb/c mice | In-vivo | 13 | Neoplastic proliferation |